<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02012452</url>
  </required_header>
  <id_info>
    <org_study_id>NURA-018-13S</org_study_id>
    <secondary_id>1IK2CX000918-01A1</secondary_id>
    <nct_id>NCT02012452</nct_id>
  </id_info>
  <brief_title>Tobacco Treatment as Augmentation for Cognitive Processing Therapy for PTSD</brief_title>
  <official_title>Tobacco Treatment as Augmentation to Cognitive Processing Therapy for PTSD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine whether tobacco affects recovery from PTSD. There are
      3 goals of the study; (1) to test if quitting tobacco prior to PTSD treatment affects
      treatment success, (2) to test how PTSD symptoms change in those who have quit tobacco
      compared to those who continue to use and (3) to explore how tobacco use and tobacco
      withdrawal symptoms change during PTSD treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed research aims to examine the effect of tobacco on PTSD symptoms and PTSD
      recovery as well as the effect of PTSD recovery on tobacco use. This study has 3 aims: (1) to
      evaluate whether tobacco use interferes with recovery from PTSD during empirically based,
      trauma focused PTSD treatment. (2) To gather preliminary data about whether tobacco use
      alleviates PTSD symptoms among continued tobacco users vs. recent quitters. (3) To explore
      the impact of recovery from PTSD treatment on tobacco use quantity and frequency, tobacco
      withdrawal symptoms, and craving for tobacco. To test these aims, the investigators propose a
      randomized two group design where 75 participants are assigned to receive either tobacco
      treatment (Contingency Management plus Cognitive Behavioral Therapy) or control treatment
      (Health Education) before completing Cognitive Processing Therapy (CPT) for PTSD. Study
      outcome variables will be PTSD symptom severity following CPT, PTSD symptom severity during
      tobacco cessation treatment, and tobacco use and tobacco withdrawal during CPT.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI moving outside VA- grant not transferable
  </why_stopped>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinician Administered PTSD Scale</measure>
    <time_frame>end of 6 week PTSD treatment</time_frame>
    <description>posttraumatic stress disorder clinician rated symptom ratings; scores range from 0-80 (with higher scores indicating greater PTSD severity)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Abstinent From Tobacco Use</measure>
    <time_frame>end of treatment</time_frame>
    <description>biochemically confirmed abstinence from tobacco using self-report, cotinine, and CO breath samples</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <condition>Tobacco Dependence</condition>
  <arm_group>
    <arm_group_label>tobacco treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>health education treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants will be provided education on a variety of health topics and will set health goals around each topic</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tobacco treatment</intervention_name>
    <description>participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment</description>
    <arm_group_label>tobacco treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health Education</intervention_name>
    <description>Participants will be provided education on a variety of health topics and will set health goals around each topic</description>
    <arm_group_label>health education treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  current tobacco use (a urine cotinine level 200ng/ml),

          -  motivation to quit (measured by the 7 on the Biener Contemplation ladder)

          -  and a current diagnosis of PTSD [as diagnosed by the Clinician Administered PTSD Scale
             for DSM-5]

        Exclusion Criteria:

          -  Exclusion criteria will include current participation in another research study,
             history of bipolar I disorder,

          -  schizophreniform disorders except for psychosis NOS due to presence of trauma-related
             sensory hallucinations,

          -  cognitive impairment (&lt;25 of the Mini Mental State Exam),

          -  current suicidality/homicidality requiring clinical intervention or a suicide attempt
             in the past year,

          -  inability to provide reliable study data (e.g., provide an adulterated urine sample,

          -  provide misinformation to study staff including stating differing information to two
             or more staff members,

          -  attempt to misrepresent self in order to avoid being excluded from the study,

          -  inability to answer study questions which are used to determine eligibility),

          -  current non-tobacco substance use disorder (abuse or dependence or a positive drug
             screen; participants who have been abstinent for greater than 3 months will be allowed
             to participate),

          -  participation within the past 6 months in trauma-focused therapy (e.g., Prolonged
             Exposure, Cognitive Processing Therapy),

          -  current use of tobacco cessation pharmacotherapy (i.e., nicotine replacement therapy
             or varenicline),

          -  current use of benzodiazepines

          -  serious or uncontrolled medical condition precluding unaided tobacco cessation
             attempts,

          -  pregnancy,

          -  a recent change in psychiatric medications (change occurred &lt;2 months prior to
             entering the study),

          -  current participation in another research study.

          -  In addition, participants must agree to keep psychiatric medication doses stable for
             the duration of the study (except for dose adjustments for changes in medication blood
             levels due to tobacco cessation), unless there is a concern for participant safety.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra Japuntich, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2013</study_first_submitted>
  <study_first_submitted_qc>December 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2013</study_first_posted>
  <results_first_submitted>January 28, 2016</results_first_submitted>
  <results_first_submitted_qc>September 6, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 27, 2016</results_first_posted>
  <last_update_submitted>September 6, 2016</last_update_submitted>
  <last_update_submitted_qc>September 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>posttraumatic stress disorder</keyword>
  <keyword>tobacco dependence</keyword>
  <keyword>cognitive behavioral therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>19 participants came in for an in-person screening visit. Of those, 9 met inclusion criteria.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Tobacco Treatment</title>
          <description>participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment
Tobacco treatment: participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment</description>
        </group>
        <group group_id="P2">
          <title>Health Education Treatment</title>
          <description>Participants will be provided education on a variety of health topics and will set health goals around each topic
Health Education: Participants will be provided education on a variety of health topics and will set health goals around each topic</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tobacco Treatment</title>
          <description>participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment
Tobacco treatment: participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment</description>
        </group>
        <group group_id="B2">
          <title>Health Education Treatment</title>
          <description>Participants will be provided education on a variety of health topics and will set health goals around each topic
Health Education: Participants will be provided education on a variety of health topics and will set health goals around each topic</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="2"/>
            <count group_id="B3" value="9"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.35" spread="7.24"/>
                    <measurement group_id="B2" value="57.05" spread="9.66"/>
                    <measurement group_id="B3" value="57.12" spread="8.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinical Administered PTSD scale</title>
          <description>Scores range from 0-80. Higher scores indicate greater PTSD severity.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.86" spread="14.51"/>
                    <measurement group_id="B2" value="50.0" spread="8.49"/>
                    <measurement group_id="B3" value="42.89" spread="13.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinician Administered PTSD Scale</title>
        <description>posttraumatic stress disorder clinician rated symptom ratings; scores range from 0-80 (with higher scores indicating greater PTSD severity)</description>
        <time_frame>end of 6 week PTSD treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tobacco Treatment</title>
            <description>participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment
Tobacco treatment: participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment</description>
          </group>
          <group group_id="O2">
            <title>Health Education Treatment</title>
            <description>Participants will be provided education on a variety of health topics and will set health goals around each topic
Health Education: Participants will be provided education on a variety of health topics and will set health goals around each topic</description>
          </group>
        </group_list>
        <measure>
          <title>Clinician Administered PTSD Scale</title>
          <description>posttraumatic stress disorder clinician rated symptom ratings; scores range from 0-80 (with higher scores indicating greater PTSD severity)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.67" spread="8.33"/>
                    <measurement group_id="O2" value="12" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Abstinent From Tobacco Use</title>
        <description>biochemically confirmed abstinence from tobacco using self-report, cotinine, and CO breath samples</description>
        <time_frame>end of treatment</time_frame>
        <population>If participants did not come the follow-up visit they were assumed to be smokers. If they attended a later follow-up visit, tobacco use was retroactively assessed.</population>
        <group_list>
          <group group_id="O1">
            <title>Tobacco Treatment</title>
            <description>participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment
Tobacco treatment: participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment</description>
          </group>
          <group group_id="O2">
            <title>Health Education Treatment</title>
            <description>Participants will be provided education on a variety of health topics and will set health goals around each topic
Health Education: Participants will be provided education on a variety of health topics and will set health goals around each topic</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Abstinent From Tobacco Use</title>
          <description>biochemically confirmed abstinence from tobacco using self-report, cotinine, and CO breath samples</description>
          <population>If participants did not come the follow-up visit they were assumed to be smokers. If they attended a later follow-up visit, tobacco use was retroactively assessed.</population>
          <units>percent abstinent</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>25 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Tobacco Treatment</title>
          <description>participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment
Tobacco treatment: participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment</description>
        </group>
        <group group_id="E2">
          <title>Health Education Treatment</title>
          <description>Participants will be provided education on a variety of health topics and will set health goals around each topic
Health Education: Participants will be provided education on a variety of health topics and will set health goals around each topic</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <description>Participant went to the ER for chest pain but it was diagnosed as reflux</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>psychosis</sub_title>
                <description>participant was reporting some delusions (e.g., that the therapist could tell the government to change the laws because the VA is part of the government) the participant later tested positive for cocaine at this visit.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sandra Japuntich</name_or_title>
      <organization>VA Boston healthcare system</organization>
      <phone>6082398018</phone>
      <email>sjjapuntich@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

